ESR1 and neoplasm: RPPA analysis of ER+ primary breast tumors obtained from patients following 2–3 weeks of treatment with the AI letrozole showed that a protein signature of insulin signaling was associated with high post-AI tumor cell proliferation (Fox et al., 2011).